Hsiu Wu
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
Papers in
-
- Patient Satisfaction in Healthcare 2
- Geriatric Care and Nursing Homes 2
-
- Antibiotic Use and Resistance 6
- Co-authors
- Minn Soe (7 shared papers)Ya-Lin A. Huang (1 shared paper)Karen W. Hoover (1 shared paper)Dawn K. Smith (1 shared paper)Maria C.B. Mendoza (1 shared paper)Jonathan R. Edwards (7 shared papers)Daniel S. Budnitz (3 shared papers)Andrea L. Benin (4 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (4 papers)Clinical Infectious Diseases (3 papers)MMWR Morbidity and Mortality Weekly Report (3 papers)Microbiology Spectrum (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- United StatesUgandaKenya
In The Last Decade
Hsiu Wu
12 papers receiving 427 citations
Hsiu Wu's Hit Papers
Peers
Comparison fields: 5 of 62
- Modeling and Simulation 79
- Infectious Diseases 317
- Applied Microbiology and Biotechnology 33
- Health 121
- Epidemiology 126
Countries citing papers authored by Hsiu Wu
This map shows the geographic impact of Hsiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu Wu more than expected).
Fields of papers citing papers by Hsiu Wu
This network shows the impact of papers produced by Hsiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu Wu. The network helps show where Hsiu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsiu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021 Hit paper breakdown → | 2021 | 189 |
| 2 | 2016 | 104 | |
| 3 | 2021 | 50 | |
| 4 | 2021 | 37 | |
| 5 | 2020 | 22 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2015 | 4 | |
| 11 | 2020 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2018 | 0 |
About Hsiu Wu
Hsiu Wu is a scholar working on General Health Professions, Applied Microbiology and Biotechnology, Infectious Diseases, Epidemiology and Clinical Biochemistry, having authored 13 papers that have together received 431 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), Patient Satisfaction in Healthcare (2 papers), HIV/AIDS Research and Interventions (2 papers), COVID-19 and healthcare impacts (2 papers), HIV, Drug Use, Sexual Risk (2 papers), Vaccine Coverage and Hesitancy (2 papers) and Geriatric Care and Nursing Homes (2 papers). The work is most often cited by research in Modeling and Simulation (79 citations), Infectious Diseases (317 citations), Applied Microbiology and Biotechnology (33 citations), Health (121 citations) and Epidemiology (126 citations). Hsiu Wu has collaborated with scholars based in United States, Uganda and Kenya. Frequent co-authors include Minn Soe, Ya-Lin A. Huang, Karen W. Hoover, Dawn K. Smith, Maria C.B. Mendoza, Jonathan R. Edwards, Daniel S. Budnitz, Andrea L. Benin, Heather Dubendris and Jennifer R. Verani. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, MMWR Morbidity and Mortality Weekly Report, Microbiology Spectrum and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.